Payment overview · 2025
General Payments
$96.83
1 reported records · 1 companies
Healthcare provider profile · identity verified
Anthony Wehbe, D.O.
Allopathic & Osteopathic Physicians|Internal Medicine · MULLICA HILL, NJ · NPI 1275731986
Verified facts
What the public records show
CMS Open Payments records show Anthony Wehbe, D.O. received $96.83 in general payments during 2025 across 1 reported records.
GENZYME CORPORATION accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| GENZYME CORPORATION | Unresolved — no canonical attribution shown | $96.83 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $96.83 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| DUPIXENT Normalized: dupixent |
Biological | GENZYME CORPORATION | $96.83 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 472 | 106 |
| Gabapentin | Gabapentin | 303 | 61 |
| Amlodipine Besylate | Amlodipine Besylate | 297 | 63 |
| Eliquis | Apixaban | 282 | 43 |
| Pantoprazole Sodium | Pantoprazole Sodium | 276 | 60 |
| Lisinopril | Lisinopril | 196 | 28 |
| Metoprolol Tartrate | Metoprolol Tartrate | 196 | 36 |
| Metoprolol Succinate | Metoprolol Succinate | 184 | 31 |
| Levothyroxine Sodium | Levothyroxine Sodium | 176 | 40 |
| Tamsulosin Hcl | Tamsulosin Hcl | 164 | 32 |
| Sertraline Hcl | Sertraline Hcl | 154 | 35 |
| Clopidogrel | Clopidogrel Bisulfate | 150 | 24 |
| Levetiracetam | Levetiracetam | 136 | 27 |
| Metformin Hcl | Metformin Hcl | 133 | 27 |
| Mirtazapine | Mirtazapine | 123 | 34 |
| Potassium Chloride | Potassium Chloride | 120 | 23 |
| Xarelto | Rivaroxaban | 118 | 15 |
| Carvedilol | Carvedilol | 113 | 24 |
| Trazodone Hcl | Trazodone Hcl | 107 | 30 |
| Losartan Potassium | Losartan Potassium | 104 | 20 |
| Hydralazine Hcl | Hydralazine Hcl | 97 | 17 |
| Furosemide | Furosemide | 96 | 38 |
| Divalproex Sodium | Divalproex Sodium | 87 | 15 |
| Famotidine | Famotidine | 85 | 18 |
| Escitalopram Oxalate | Escitalopram Oxalate | 77 | 22 |
| Olanzapine | Olanzapine | 74 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 73 | 13 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 67 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 66 | 14 |
| Baclofen | Baclofen | 64 | 14 |
| Fluticasone Propionate | Fluticasone Propionate | 62 | 20 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 61 | 15 |
| Donepezil Hcl | Donepezil Hcl | 59 | 15 |
| Aripiprazole | Aripiprazole | 58 | suppressed |
| Omeprazole | Omeprazole | 56 | 15 |
| Montelukast Sodium | Montelukast Sodium | 55 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 53 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 52 | 25 |
| Pravastatin Sodium | Pravastatin Sodium | 48 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 46 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 45 | 16 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 44 | 13 |
| Hydrochlorothiazide | Hydrochlorothiazide | 44 | suppressed |
| Prednisone | Prednisone | 43 | 17 |
| Simvastatin | Simvastatin | 43 | 11 |
| Carbamazepine | Carbamazepine | 42 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 42 | suppressed |
| Torsemide | Torsemide | 42 | 11 |
| Glipizide | Glipizide | 41 | suppressed |
| Latanoprost | Latanoprost | 41 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 41 | 11 |
| Ibuprofen | Ibuprofen | 40 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 38 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 37 | 19 |
| Benztropine Mesylate | Benztropine Mesylate | 36 | suppressed |
| Methocarbamol | Methocarbamol | 36 | suppressed |
| Risperidone | Risperidone | 36 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 36 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 35 | 27 |
| Bumetanide | Bumetanide | 34 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 34 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 32 | 17 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 30 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 29 | suppressed |
| Digoxin | Digoxin | 29 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 29 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 28 | suppressed |
| Entresto | Sacubitril/Valsartan | 28 | suppressed |
| Diltiazem 24hr Er (Xr) | Diltiazem Hcl | 27 | suppressed |
| Scopolamine | Scopolamine | 27 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 27 | suppressed |
| Nifedipine Er | Nifedipine | 26 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 26 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 25 | suppressed |
| Lubiprostone | Lubiprostone | 25 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 25 | suppressed |
| Timolol Maleate | Timolol Maleate | 25 | suppressed |
| Ezetimibe | Ezetimibe | 24 | suppressed |
| Jentadueto | Linagliptin/Metformin Hcl | 24 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 24 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 23 | suppressed |
| Januvia | Sitagliptin Phosphate | 23 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 22 | suppressed |
| Anastrozole | Anastrozole | 21 | suppressed |
| Brilinta | Ticagrelor | 21 | suppressed |
| Rexulti | Brexpiprazole | 21 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 20 | suppressed |
| Lactulose | Lactulose | 20 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 20 | 12 |
| Tivicay | Dolutegravir Sodium | 20 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 19 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 19 | suppressed |
| Finasteride | Finasteride | 19 | suppressed |
| Lamotrigine | Lamotrigine | 19 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 19 | suppressed |
| Topiramate | Topiramate | 19 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 18 | suppressed |
| Amantadine | Amantadine Hcl | 17 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 17 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 16 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 16 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 16 | suppressed |
| Cephalexin | Cephalexin | 16 | 14 |
| Incruse Ellipta | Umeclidinium Bromide | 16 | suppressed |
| Memantine Hcl | Memantine Hcl | 16 | suppressed |
| Neupro | Rotigotine | 16 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 16 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 16 | suppressed |
| Spironolactone | Spironolactone | 16 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 15 | 14 |
| Insulin Lispro | Insulin Lispro | 15 | 11 |
| Mupirocin | Mupirocin | 15 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 15 | 12 |
| Valsartan | Valsartan | 15 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 15 | suppressed |
| Budesonide | Budesonide | 14 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 14 | 12 |
| Minocycline Hcl | Minocycline Hcl | 14 | suppressed |
| Novolog Mix 70-30 | Insulin Aspart Prot/Insuln Asp | 14 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 13 | suppressed |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 13 | suppressed |
| Glimepiride | Glimepiride | 13 | suppressed |
| Hydroxyurea | Hydroxyurea | 13 | suppressed |
| Lansoprazole | Lansoprazole | 13 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 13 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 13 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 13 | suppressed |
| Ozempic | Semaglutide | 13 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 13 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 13 | suppressed |
| Acetic Acid | Acetic Acid | 12 | suppressed |
| Chlorthalidone | Chlorthalidone | 12 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 12 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 12 | suppressed |
| Gemfibrozil | Gemfibrozil | 12 | suppressed |
| Allopurinol | Allopurinol | 11 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 11 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 11 | suppressed |
| Pentoxifylline | Pentoxifylline | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $96.83 · 1 records | GENZYME CORPORATION | DUPIXENT | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error